|
ACTU Actuate Therapeutics Inc 1652935 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-5,625,749.00 |
| Balance Sheet |
|
Current Assets
|
$8,519,448.00 |
|
Assets
|
$8,911,286.00 |
|
Current Liabilities
|
$4,721,897.00 |
|
Liabilities
|
$5,126,888.00 |
|
Equity
|
$3,784,398.00 |
|
Shares Out
|
23711677.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-5,017,327.00 |
| Market Analysis |
Market Cap
|
$27,742,662.09 |
|
Price
|
$1.13 |
|
BVPS
|
0.16 |
|
PB
|
7.31 |
|
EPS
|
-0.24 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:40 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:39 |
|
| Apr |
May |
Jun |
| 2026-03-26 |
-1.06 |
|
|
2026-05-14 |
-0.24 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-0.25 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ACTU documents filed with the SEC.
ACTU Filings
Clear
